Your browser doesn't support javascript.
loading
Unmet needs in ankylosing spondylitis patients receiving tumour necrosis factor inhibitor therapy; results from a large multinational real-world study.
Deodhar, A; Strand, V; Conaghan, P G; Sullivan, E; Blackburn, S; Tian, H; Gandhi, K; Jugl, S M; Alten, R.
Afiliação
  • Deodhar A; 1Oregon Health and Science University, Portland, OR USA.
  • Strand V; Biopharmaceutical Consultant, Portola Valley, CA USA.
  • Conaghan PG; 3Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds & NIHR Leeds Biomedical Research Centre, Leeds, UK.
  • Sullivan E; Adelphi Real World, Bollington, UK.
  • Blackburn S; Adelphi Real World, Bollington, UK.
  • Tian H; 5Novartis Pharmaceuticals Corporation, East Hanover, NJ USA.
  • Gandhi K; 5Novartis Pharmaceuticals Corporation, East Hanover, NJ USA.
  • Jugl SM; 6Novartis Pharma AG, Basel, Switzerland.
  • Alten R; 7Schlosspark-Klinik, University Medicine, Berlin, Germany.
BMC Rheumatol ; 4: 19, 2020.
Article em En | MEDLINE | ID: mdl-32159075
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: BMC Rheumatol Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: BMC Rheumatol Ano de publicação: 2020 Tipo de documento: Article